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Abstract
This  study  investigated  the  -glucosidase  inhibitory  effect  and  determined  the  concentration  of  some  inorganic
constituents in P. amarus ash. Oral glucose and sucrose tolerance test were performed on normal mice. In vitro -glucosidase
inhibitory activity was evaluated by using yeast a-glucosidase. The element concentrations were measured by inductively
coupled plasma (ICP) spectroscopy. Single oral administration of P. amarus ash did not show antihyperglycemic effect after
glucose  administration,  but  decreased  blood  glucose  level  after  sucrose  administration.  The  ash  showed  -glucosidase
inhibitory activity in vitro with IC50 of 982 mg/mL. The concentrations of K, Ca, Mg, Mn, Fe, Zn, Cu, Pb, Cr, Ni and Co in
P. amarus ash were 35049.80±340.64, 3337.24±52.10, 1368.52±13.29, 90.81±1.34, 87.68±1.15, 18.28±0.22, 4.69±0.07, 1.07±0.15,
0.29±0.03, 0.20±0.04 and 0.10±0.02 mg/g, respectively. These results indicate that the antihyperglycemic effect of P. amarus
ash might be partly due to the -glucosidase inhibitory activity of the inorganic constituents.
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1. Introduction
-glucosidases are enzymes located in the brush-
border surface membrane of intestinal cells involving in
breaking down carbohydrates such as starch, glycogen  and
disaccharides  to  glucose  by  hydrolyzing  terminal  non-
reducing 1-4 linked -glucose residues to release a single -
glucose molecule (Chiba, 1997). Inhibition of -glucosidases
is important to control postprandial hyperglycemia in type 2
diabetes mellitus (American Diabetes Association, 2001).
There is increasing evidence suggesting that postprandial
hyperglycemia strongly correlates with diabetic complica-
tions especially those to the cardiovascular system (Tanaka,
2012). Acarbose, an -glucosidase inhibitor, is the first line
drug  for  reducing  postprandial  blood  glucose  in  diabetic
patients and was reported to reduce the relative risk of cardio-
vascular event in patients with impaired glucose tolerance
and type 2 diabetes (Hanefeld, 2007; Breuer, 2003).
Despite the numerous modern medications to reduce
blood glucose, the increasing use in diabetic patients of
complementary and alternative medicine, especially herbs,
dietary and mineral supplements, have been reported (Yeh et
al., 2003). A number of herbs traditionally used for diabetes
have been recorded for antihyperglycemic activity such as
Allium sativum, Aloe vera, Coccinia indica, Eugenia jam-
bolana, Gymnema sylvestre, Ipomoea batatas, Momordica
charantia, Ocimum sanctum, Silybum marianum, Trigonella
foenum-graecum, Phyllanthus amarus, Piper sarmentosum,
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Pterocarpus marsupium, Tinospora cordifolia, etc. (Suk-
somboon et al., 2011; Modak et al., 2007; Yeh et al., 2003).
Phyllanthus amarus Schum. & Thonn. which belongs to the
family  Euphorbiaceae  is  a  small  herb  well  known  for  its
medicinal properties. Various pharmacological activities of
P. amarus including antiviral, antibacterial, antiplasmodial,
anti-inflammatory, antimalarial, antimicrobial, anticancer,
antidiabetic, hypolipidemic, antioxidant, hepatoprotective,
nephroprotective, and diuretic properties have been reported
(Patel et al., 2011, Pramyothin et al., 2007, Wongnawa et al.,
2006). The main active constituents of  P. amarus are lignans
(phyllanthin, hypophyllanthin, niranthin, etc.), flavonoids
(quercetin, astragalin, rutin, kaempferol, etc.), ellagitannins
(gallic acid, ellagic acid, etc.), alkaloids (securinine, dihydro-
securinine, etc.), triterpines (lupeol),  sterol, and volatile oil
(Patel et al., 2011). Although medicinal plants contain both
organic and inorganic constituents, most of the studies done
so far on hypoglycemic herbs were carried out with organic
active  principles  (Modak  et  al.,  2007).  However,  some  in-
organic elements such as potassium (K), calcium (Ca), zinc
(Zn), magnesium (Mg), manganese (Mn), copper (Cu) and
trace elements such as chromium (Cr), vanadium (V), cobalt
(Co), molybdenum (Mo) and tungsten (W) have potential roles
for glucose homeostasis (Pandey et al., 2012, Wiernsperger
and Rapin, 2010). Most  research works on hypoglycemic
effect of P. amarus have also been carried out on the organic
compounds (Patel et al., 2011), while little attention has been
paid on the role of its inorganic constituents.
In the present work, the in vivo -glucosidase inhibi-
tory effect of the inorganic components in the ash of P. amarus
was  evaluated  in  normal  fasted  mice  by  oral  glucose  and
sucrose tolerance tests. The in vitro -glucosidase inhibitory
effect was also tested by using yeast -glucosidase. More-
over,  the  inorganic  elemental  analysis  of  P. amarus  was
carried out using inductively coupled plasma technique.
2. Materials and Methods
2.1 Chemicals
The drugs used in this study included tolbutamide
(Ajax Finechem Pty Ltd), Glucobay
 (acarbose 50 mg/tab),
yeast -glucosidase (Sigma), p-nitrophenyl -D-glucopyra-
noside  (Sigma).  All  other  chemicals  and  solvents  were  of
analytical reagent grade. Water was purified by Milli Q Water
Purification System, Millipore, USA.
2.2 Preparation of  P. amarus ash
Dried powder of P. amarus was purchased from
Lampang Herb Conservation, Lampang, Thailand, and was
identied by Assoc. Prof. Tanomjit Supavita, School of Phar-
macy, Walailak University, Nakhon Si Thammarat. Twenty
grams of P. amarus powder in a crucible was placed in an
electric muffle furnace and maintained at 430-450°C overnight
to destroy any organic compounds present in the powder
(Sahrawat et al., 2002). After cooling, the ash was removed
from the crucible and kept in a vacuum desiccator. The yield
of the ash was 5.7 % w/w.
2.3 Animals
Male ICR mice, weighing 20-30 g, were obtained from
the Southern Laboratory Animal Facility, Prince of Songkla
University,  Thailand.  The  animals  were  housed  in  the
controlled room at temperature 25±2°C with a 12 hours light/
dark cycle. They were allowed to acclimatize for one week
before the experiments and were given free access to standard
laboratory feed and water. The experimental protocol was
approved by the Institutional Committee for Ethical Use of
Animals,  Prince  of  Songkla  University,  Thailand  (Ref  19/
2012).
2.4 Experimental protocol
The animals were divided into 4 groups, with 6 mice
each and were treated as follows:
Group I (control group) was administered with 10 %
gum acacia, 10 mL/kg
Group II was administered with P. amarus ash (90 mg/
kg)
Group III was administered with tolbutamide (300 mg/
kg)
Group IV was administered with acarbose (40 mg/kg)
The selected dose of  P. amaus ash was 90 mg/kg to
avoid  toxic  effect  of  some  metals  (Kar  et  al.,  1999).  The
powder of tolbutamide, acarbose and the ash were suspended
in 10 % gum acacia prior to the administration by the volume
of 10 mL/kg.
2.5 Glucose/Sucrose tolerance test
After being fasted overnight, blood samples from all
mice were obtained from the tail vein. Then the mice were
orally given each drug through feeding tube. At 30 min after
the drug administration, the substrate solution (glucose or
sucrose, 2 g/kg body weight) was administered to the mice.
Five more blood samples were collected at 15-, 30-, 60-, 120-,
and  180-min  intervals.  The  blood  glucose  levels  were
measured using a glucometer (GlucoDr , All Medicus Co.,
Ltd).
2.6 In vitro -glucosidase inhibitory assay
-glucosidase  inhibitory  activity  was  determined
according to Kumar et al. (2010) and Gowri et al. (2007) with
some modification. In brief, 50 L of test sample (50-1250
g/mL in phosphate buffer, pH 6.8) was reconstituted in 100
L of 100 mM phosphate buffer, pH 6.8 and incubated with
50 L yeast -glucosidase (0.25 U/mL in phosphate buffer)
for 15 min at 37°C before 50 L of substrate (5 mM p-nitro-
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and then incubated for 15 min at 37°C. The reaction was
stopped by adding 1 mL of Na2CO3 (0.1 M). Release of p-
nitrophenol was measured at 405 nm by spectrophotometer
(Spectronic Genesys 20). Individual blank for test sample was
prepared by replacing substrate with 50 L of the buffer. The
control sample was prepared in similar manner but using 50
L of buffer in place of test sample. All the tests were run in
triplicate. The percentage of enzyme inhibition was calculated
as (1-B/A)x100, where A represents the absorbance of control
sample, B represents the absorbance of test sample. The IC50
values  were  determined  by  regression  analysis  of  the  data
for at least five concentrations of sample.
2.7 Assay of inorganic elements in P. amarus
Two hundred milligrams of P. amarus dry powder or
100 mg of the ash was digested with 2 mL of conc. nitric acid
and incubated at 90°C for 1 h, then adjusted with deionized
water to the volume of 10 mL. The digested sample was used
for the assay of inorganic elements using the ICP spectro-
meter (PerkinElmer
®, Optima 4300DV, USA).
2.8 Statistical analysis
All  the  results  were  expressed  as  mean ± standard
deviation. Statistical analysis was performed using one way
analysis of variance (ANOVA), followed by least significant
difference  (LSD)  test.  Differences  were  considered  to  be
statistically different when p value was  < 0.05.
3. Results
3.1 Oral glucose and sucrose tolerance tests
In oral glucose tolerance test, there was no significant
difference in the blood glucose level and the area under curve
(AUC) between P. amarus ash-treated, acarbose-treated and
the control group, whereas those of the tolbutamide-treated
group  were  lower  when  compared  with  the  control  group
(Figures 1, 2). In contrast, in the oral sucrose tolerance test,
the postprandial blood glucose level at each time measured
from T30-T180 minute, as well as the AUC, in the acarbose-,
tolbutamide- and P. amarus ash-treated group were signifi-
cantly lower than the control group (Figures 3, 4).
3.2 In vitro a-glucosidase inhibitory activity
The  ash  of  P. amarus  showed  inhibitory  activity
against yeast -glucosidase with the maximum inhibition of
50.04±3.55 % at the concentration of 1 mg/mL,  compared to
59.23±4.12 % of acarbose at the concentration of 1.25 g/
mL.  The IC50 of P. amarus ash was 982.13±162.69 mg/mL,
whereas that of acarbose was 816.87±99.65 g/mL (Table 1,
Figure 5).
Figure 1. Effects of P. amarus ash, tolbutamide and acarbose on
oral glucose tolerance in normal mice (X±SD, N=6, * sig-
nificantly different from control, p<0.05)
Figure 2. The area under the curves in oral glucose tolerance test
after administration of P. amarus ash, tolbutamide and
acarbose in normal mice (X±SD, N=6, * significantly
different from control,  p<0.05)
Figure 3. Effects of P. amarus ash, tolbutamide and acarbose on
oral  sucrose  tolerance  in  normal  mice  (X±SD,  N=6,
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3.3 Concentration of some elements in P. amarus
Table 2 shows some inorganic constituents found in
the dry powder and ash of P. amarus. The concentrations of
K, Ca, Mg, Mn, Fe, Zn, Cu, Pb, Ni, Cr, Se, V, As, Co and Cd in
P. amarus dry powder were 2334.17±28.82, 1596.50±37.40,
519.00±12.70, 36.00±0.42, 27.30±1.32, 20.85±0.03, 1.80±0.05,
0.70±0.08, 0.25±0.01, 0.20±0.01, 0.20±0.10, 0.15±0.05, 0.15±
0.04, 0.05±0.01 and 0.05±0.01 g/g, respectively.  Those of
K, Ca, Mg, Mn, Fe, Zn, Cu, Pb, Ni, Cr and Co in the ash were
35049.80±340.64, 3337.24±52.10, 1368.52±13.29, 90.81±1.34,
87.68±1.15, 18.28±0.22, 4.69±0.07, 1.07±0.15, 0.20±0.04,
0.29±0.03, and 0.10±0.02 g/g, respectively, whereas As, Cd,
Se, and V were not detectable at the detection limit of 2, 0.1,
5, and 0.05 g/g ash, respectively.
4. Discussion and Conclusions
To investigate the in vivo -glucosidase inhibitory
activity, we compared the effects of P. amarus ash on oral
glucose  and  sucrose  tolerance  focusing  on  postprandial
blood glucose rather than fasting blood glucose. The post-
prandial blood glucose profile is determined by carbohydrate
absorption,  insulin  and  glucagon  secretion,  and  their  co-
ordinated effects on glucose metabolism in the liver and
peripheral tissues (American Diabetes Association, 2001).
Sucrose is a disaccharide of glucose and fructose with an
-1,2  glycosidic  linkage.  It  is  hydrolyzed  to  glucose  and
fructose by sucrase, a kind of a-glucosidase, and is absorbed
by  the  small  intestine  (Drozdowski  and  Thomson,  2006).
Drugs  with  -glucosidase  inhibitory  activity  such  as
acarbose decreased oral absorption of sucrose resulting in
inhibition of the increase in blood glucose but did not inhibit
absorption of glucose which is a monosaccharide (Hayakawa
et al., 1984). The present study showed that P. amarus ash
and  acarbose  did  not  suppress  hyperglycemia  on  oral
glucose tolerance test, whereas tolbutamide, a sulfonylurea
antidiabetic drug which stimulate insulin secretion, decreased
blood  glucose  level.  This  suggests  that  the  inorganic
constituents of P. amarus ash at the dose of 90 mg/kg may
not be involved in the reduction of glucose absorption. In
Table 1. Inhibitory effect  of  P. amarus  ash and acarbose on
yeast -glucosidase  (X± SD, N=3)
Maximum % inhibition IC50
(concentration, mg/mL) (g/mL)
P. amarus ash 50.04±3.55 (1.0)    982.13±162.69
Acarbose    59.23±4.12 (1.25) 816.87±99.65
Table 2. Concentrations of some inorganic constituents in
P. amarus (X±SD, N=3)
 Concentration (g/g)
Elements
Dry powder    Ash
K 2334.17±28.82 35049.80±340.64
Ca 1596.50±37.40 3337.24±52.10
Mg   519.00±12.70 1368.52±13.29
Mn   36.00±0.42   90.81±1.34
Fe   27.30±1.32   87.68±1.15
Zn   20.85±0.03   18.28±0.22
Cu      1.80±0.05      4.69±0.07
Pb      0.70±0.08      1.07±0.15
Cr     0.20±0.01      0.29±0.03
Ni     0.25±0.01     0.20±0.04
Co     0.05±0.01     0.10±0.02
As    0.15±0.04    ND
Cd    0.05±0.01    ND
Se    0.20±0.10    ND
V    0.15±0.05    ND
ND = not detectable (detection limit of As, Cd, Se,
V =  2, 0.1, 5, and 0.05 g/g ash, respectively)
Figure 5. Inhibitory effect of P. amarus ash and acarbose on yeast
-glucosidase.
Figure 4. The area under the curves in oral sucrose tolerance test
after administration of P. amarus ash, tolbutamide and
acarbose  in  normal  mice  (X±SD,  N=6, * significantly
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contrast, in the oral sucrose tolerance test, P. amarus ash
suppressed hyperglycemia after administration of sucrose,
a disaccharide, as did acarbose, an -glucosidase inhibitor,
suggesting that the inorganic substances in P. amarus ash
may play a role in decreasing glucose absorption which may
be  due  to  the  inhibition  of -glucosidase  activity  in  the
intestine.  This  result  was  consistent  with  the  previously
reported antidiabetic effect of P. amarus aqueous extract
(Patel et al., 2011) which might possibly be exerted in part
through some dissolved inorganic constituents via -gluco-
sidase inhibitory activity. To confirm this activity, in vitro
-glucosidase inhibitory activity was carried out by using
yeast a-glucosidase. It was found that P. amarus ash showed
-glucosidase  inhibitory  activity  with  nearly  the  same
potency  as  acarbose  when  considered  by  the  maximum
percent inhibition and IC50 (Table 1, Figure 5). However, the
maximum percent inhibition of P. amarus ash was limited by
its solubility. The ethanol and hexane extract of P. amarus
have  also  been  reported  to  possess  -amylase  inhibitory
activity in vitro (Tamil et al., 2010, Ali et al., 2006).
Some  recent  reports  have  shown  that  inorganic
compounds such as CuSO4, ZnSO4, VOSO4, NiSO4 and FeSO4
possess -glucosidase inhibitory activity in vitro (Zeng et
al., 2012, Yoshikawa et al., 2010, Yoshikawa et al., 2009), and
the synergistic inhibition of Cu, Zn, V and genistein (fla-
vonoids) on -glucosidase was also demonstrated (Wang et
al., 2004). Therefore, in the present work we determined some
inorganic constituents in P. amarus which may be involved in
glucose homeostasis using the ICP technique. Table 2 shows
that the major inorganic constituents in P. amarus  dry
powder are K, Ca and Mg (2334-519 g/g), whereas Mn, Fe,
Zn and Cu were found in moderate amount (36-2 g/g), Ni,
Cr, Se, V and Co were at trace level (0.25-0.05 g/g). When
compared to the amount reported elsewhere, K, Ca, Mg, Mn,
Fe and Cu found in the present study were lower (<10 folds)
than those reported previously (Adedapo et al., 2004). This
variation might be due to the different amount of these metals
in different area where the plant grows. It is noted that some
elements such as Se and V, while existing in dry plant, were
not detectable in the ash. It is possible that they might be
lost due to volatilization during ashing (Welna et al., 2011).
Some elements found in P. amarus have been reported
to have an effect on glucose homeostasis. For example, K,
Ca, Mg, Cr, Mn, Cu, V and Zn are responsible for the secre-
tion of insulin from beta cells of the islets of Langerhans, are
involved in insulin receptor binding and signaling pathway,
and are cofactors of many enzymes in glycolysis (Pandey et
al., 2012, Wiernsperger and Rapin, 2010). There is accumu-
lating evidence that the metabolism of several trace elements
is altered in diabetes mellitus.  Blood level of Zn, Mn, Cr and
Mg were found to be lower in diabetic patients than in aged-
match  healthy  controls  (Kazi  et  al.,  2008,  Campbell  and
Nadler,  2004;  Salgueiro  et  al.,  2001).  Supplementation  of
such elements is beneficial for improving insulin resistance,
glucose tolerance and oxidative stress in some experiments
(Wiernsperger and Rapin, 2010). The results from this study
and previous reports suggest that the beneficial effect of P.
amarus in controlling blood glucose level involves both
organic and inorganic compounds.
Concerning the safety from toxic metals in herbs, we
also determined the concentrations of Pb, As and Cd in P.
amarus.  Pb was found at 0.70 g/g, whereas As and Cd were
0.15 and 0.05 g/g, respectively. However, the amount of
these toxic metals were far less than the allowance limit of
heavy metals in herb products (Pb=10 g/g , As=20 g/g,
Cd=0.3 mg/g, WHO, 2004).
In conclusion, the present study demonstrates that
P. amarus contains some inorganic constituents which have
beneficial  effect  on  glucose  homeostasis  in  part  via  -
glucosidase inhibitory activity, whereas some toxic metals
such as Pb, As and Cd were found in negligible amount.
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